CA Patent

CA2057081A1 — Translucent antiperspirant compositions

Assigned to Dow Silicones Corp · Expires 1992-06-22 · 34y expired

What this patent protects

TRANSLUCENT ANTIPERSPIRANT COMPOSITIONS ABSTRACT Translucent antiperspirant compositions are comprised of an antiperspirant active in a gel base. The translucent antiperspirant composition is comprised of (A) 50 to 95% by weight of an anhydrous carrier liquid selecte…

USPTO Abstract

TRANSLUCENT ANTIPERSPIRANT COMPOSITIONS ABSTRACT Translucent antiperspirant compositions are comprised of an antiperspirant active in a gel base. The translucent antiperspirant composition is comprised of (A) 50 to 95% by weight of an anhydrous carrier liquid selected from volatile silicones, low viscosity silicones, anhydrous monoalcohols, polyalcohols, fatty alcohols, alcohol soluble emollients and mixtures thereof; (B) 5 to 20% by weight of a metal stearate; (C) 1 to 25% of an encapsulated antiperspirant active selected from an encapsulated aluminum salt, an encapsulated aluminum-zirconium salt and mixtures thereof and optionally (D) 0.5 to 10 weight percent of a silicone carboxy acid. The compositions do not leave a visible white residue when they are applied to the skin.

Drugs covered by this patent

Patent Metadata

Patent number
CA2057081A1
Jurisdiction
CA
Classification
—
Expires
1992-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Dow Silicones Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.